Durability of regenerated articular cartilage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year.

1988 ◽  
Vol 70 (4) ◽  
pp. 595-606 ◽  
Author(s):  
S W OʼDriscoll ◽  
F W Keeley ◽  
R B Salter
1993 ◽  
Vol 1 (1) ◽  
pp. 19-23
Author(s):  
Steve Morris ◽  
Amis Freiberg ◽  
Leonard Harris

S Morris, a Freiberg, L Harris. Early experience with hand continuous passive motion. Can J Plast Surg 1993; 1 (1): 19-23. Clinical experience with continuous passive motion (CPM) has increased in recent years. However, little information is available in the literature of objective evaluation of the results obtained using this treatment modality. The purpose of this study was to review both the indications for hand CPM at the Toronto Western Hospital. Toronto. Ontario, and the course and the outcome of the patients treated. Between 1984 and 1989 the Mobilimb H1 CPM was used on 43 patients for a mean period of 39±6 days (mean total hours of CPM 741+84 h). Indications for hand CPM included hand trauma, capsulectomy and tenolysis and other hand conditions. Mean follow-up was 32+3 months. Overall, hand CPM was well tolerated and highly effective in relieving hand pain and increasing active and passive range of motion. Compliance was excellent.


2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Rodrigo Mardones ◽  
Alessio Giai Via ◽  
Gennaro Pipino ◽  
Claudio M. Jofre ◽  
Sara Muñoz ◽  
...  

Abstract Background Full-thickness articular cartilage injury of the knee is a major cause of disability. The aim of this study is to assess the outcome of patients treated with differentiated to chondrocytes bone marrow mesenchymal stem cells (BM-MSCs) cultured on a collagen type I/III (Chondro-Gide®) scaffold. The secondary aim was to confirm the absence of adverse events. Methods Fifteen patients (19 knees) with symptomatic full-thickness cartilage defects of the knee were enrolled. Bone marrow was harvested from the iliac crest, BM-MSCs were prepared, and expanded cells were grown in a standard medium or in a standard culture medium containing TGF-β. BM-MSCs differentiated to chondrocytes were seeded in a porcine collagen type I/III scaffold (Chondro-Gide®) and cultured in TGF-β containing media. After 4 weeks, the membrane was sutured on the cartilage defect. All patients underwent plain radiographs (antero-posterior, lateral, and axial view of the patella) and MRI of the affected knee. The Oxford knee score, the Lyhsolm scale, and the VAS score were administered to all patients. At final follow-up a MRI for the study of articular cartilage was undertaken. Results The mean size of the cartilage lesions was 20 × 17 mm (range, 15 × 10 mm–30 × 30 mm). At final follow-up, the median Oxford knee score and Lyhsolm scale scores significantly improved from 29 (range 12–39; SD 7.39) to 45 (range 24–48; SD 5.6) and from 55.5 (range 25–81; SD 17.7) to 94.5 (58–100; SD 10.8), respectively. Pain, according to the VAS score, significantly improved. Sixty percent of patients reported their satisfaction as excellent, 20% as good, 14% as fair, and 1 patient as poor. Conclusion The treatment of full-thickness chondral injuries of the knee with differentiated to chondrocytes BM-MSCs and Chondro-Gide® scaffold showed encouraging outcomes. Further studies involving more patients, and with longer follow-up, are required to evaluate the effectiveness of the treatment and the long-term results.


Sign in / Sign up

Export Citation Format

Share Document